EVALDO STANISLAU AFFONSO DE ARAUJO

(Fonte: Lattes)
Índice h a partir de 2011
7
Lattes
Projetos de Pesquisa
Unidades Organizacionais
Instituto Central, Hospital das Clínicas, Faculdade de Medicina - Médico
LIM/47 - Laboratório de Hepatologia por Vírus, Hospital das Clínicas, Faculdade de Medicina

Filtros

Limpar filtros

Configurações

search.filters.applied.f.dateIssued: 2012 ×

Resultados de Busca

Agora exibindo 1 - 3 de 3
  • article 2 Citação(ões) na Scopus
    A Summary of the 18th International Symposium on Hepatitis C Virus and Related Viruses
    (2012) POLYAK, Stephen J.; MORISHIMA, Chihiro; SCOTT, John D.; COX, Andrea; ARAUJO, Evaldo Stanislau Affonso de; HIGGS, Martin R.; LOO, Yueh-Ming; GOLDEN-MASON, Lucy; LINDENBACH, Brett D.; BAUMERT, Thomas F.; RANDALL, Glenn; GALE JR., Michael
  • article 34 Citação(ões) na Scopus
    Low Sensitivity of NS1 Protein Tests Evidenced during a Dengue Type 2 Virus Outbreak in Santos, Brazil, in 2010
    (2012) FELIX, Alvina Clara; ROMANO, Camila Malta; CENTRONE, Cristiane de Campos; RODRIGUES, Celia Lima; VILLAS-BOAS, Lucy; ARAUJO, Evaldo Stanislau; MATOS, Andreia Manso de; CARVALHO, Karina Inacio; MARTELLI, Celina Maria Turchi; KALLAS, Esper Georges; PANNUTI, Claudio Sergio; LEVI, Jose Eduardo
    In 2010, a large outbreak of dengue occurred in Santos, Brazil. The detection of the NS1 antigen was used for diagnosis in addition to the detection of IgG, IgM, and RNA. A large number of NS1 false-negative results were obtained. A total of 379 RNA-positive samples were selected for thorough evaluation. NS1 was reactive in 37.7% of cases. Most of the cases were characterized as a secondary infection by dengue 2 virus. Sequencing of NS1 positive and negative isolates did not reveal any mutation that could justify the diagnostic failure. Use of existing NS1 tests in the Brazilian population may present a low negative predictive value, and they should be used with caution, preferentially after performing a validation with samples freshly obtained during the ongoing epidemic.
  • conferenceObject
    Lack of association between SOCS3 rs4969170 and interleukin 28B genes with therapeutic response in Brazilian HCV carriers treated with PEG-IFN/RBV
    (2012) MELO, Carlos E.; ARAUJO, Evaldo S.; MANCHIERO, Caroline; MARTINS, Luciane P.; TENGAN, Fatima M.; BARONE, Antonio A.
    Chronic HCV infections are related with the production of inappropriate cytokine levels in inflammatory and immune response. IFN-α must activate a signal transduction cascade that involves different intracellular proteins driving interferon-inducible genes to be activated. The proteins suppressor of cytokine signaling (SOCS) represents the main cellular mechanism for cytokine (such as IL10 and IFN) negative regulation. Immune responses may be associated with SOCS3 production driven by therapy against HCV and it seems to be regulated by single nucleotide polymorphisms (SNPs) within SOCS3 gene. Recently, genome-wide association studies have linked response to PEG-IFN/RBV therapy with SNPs near the IL28B gene (rs12979860), encoding for interferon-lambda-3 (IL28B). The rs12979860 CC genotype is associated with a greater rate of sustained virological response (SVR) than the CT or TT genotypes in different HCV patients populations. In this study, we evaluated the frequencies of SOCS3 and IL28B polymorphisms genes and their association with the response to IFN based antiviral therapy in chronic hepatitis C infection. After IRB ethics approval, frozen samples from 142 HCV Genotype-1 infected Brazilian patients were analyzed. Genomic DNA from patients classified as responders (R=71) and nonresponders (NR=71) to a PEG-IFN/RBV therapy were used in this study. The SNPs near the IL28B (rs12979860) and SOCS3 (rs4969170) genes were examined using an assay with allele specific PCR probes. According recent publications, IL28B CC genotype was considered the more favorable profile to reach Sustained Virologic Response (SVR). Regarding SOCS3 AA genotype was also recently strongly associated with failure of the IFN-α based therapy. The results are summarized in the table 1. As expected IL28B CC SNP was associated with a better response to antiviral therapy. Conversely, we could not observe a clear association between the polymorphism rs4969170 SOCS3 gene and lack of response to IFN based therapy in our population. Therefore we conclude that the SOCS3 rs4969170 was not as good as IL28B on predicting therapy outcome for HCV.